More

    Moderna to sue BioNTech/Pfizer over COVID vaccine

    spot_img

    Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna’s mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday.

    A widely distributed COVID vaccine developed by Pfizer and BioNTech, called Comirnaty, infringes on patents Moderna filed between 2010 and 2016, the company alleged, adding that mRNA technology was vital to the development of its COVID vaccine.

    PHOTO: The Moderna headquarters, Nov. 30, 2020, in Cambridge, Mass.

    The Moderna headquarters, Nov. 30, 2020, in Cambridge, Mass.

    Maddie Meyer/Getty Images

    Moderna accused Pfizer and BioNTech of copying the mRNA technology without its permission in order to develop Comirnaty, the press release said.

    “We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the COVID-19 pandemic,” Moderna CEO Stéphane Bancel said in a statement.

    PHOTO: A medical workers holds a vial of the new Moderna Covid-19 vaccine before filling syringes with it in Needham, Mass., June 21, 2022.

    A medical workers holds a vial of the new Moderna Covid-19 vaccine before filling syringes with it in Needham, Mass., June 21, 2022.

    Joseph Prezioso/AFP via Getty Images, FILE

    “This foundational platform, which we began building in 2010, along with our patented work on coronaviruses in 2015 and 2016, enabled us to produce a safe and highly effective COVID-19 vaccine in record time after the pandemic struck,” he added. “As we work to combat health challenges moving forward, Moderna is using our mRNA technology platform to develop medicines that could treat and prevent infectious diseases like influenza and HIV, as well as autoimmune and cardiovascular diseases and rare forms of cancer.”

    In October 2020, Moderna vowed to forego enforcement of its COVID-related patents amid the pandemic, the company said. In March, however, the pandemic “entered a new phase and vaccine supply was no longer a barrier to access in many parts of the world,” the company added.

    Moderna would never enforce patents in 92 middle- and low-income countries involved with a financing agreement at the global vaccine alliance Gavi, the company said. But, in other markets, Moderna expected competitors to respect intellectual property rights, it added.

    In response to a request for comment, Pfizer said: “We have not been served and are unable to comment at this time.”

    BioNTech did not immediately respond to a request for comment.

    Source link

    Share

    All countries
    698,521,223
    Total confirmed cases
    Updated on November 30, 2023 5:56 am
    Italy
    26,363,670
    Total confirmed cases
    Updated on November 30, 2023 5:56 am
    Spain
    13,914,811
    Total confirmed cases
    Updated on November 30, 2023 5:56 am
    Iran
    7,624,112
    Total confirmed cases
    Updated on November 30, 2023 5:56 am
    Germany
    38,652,262
    Total confirmed cases
    Updated on November 30, 2023 5:56 am

    Latest Updates

    Frequently Asked Questions

    spot_img

    Related Articles

    FDA clears new Covid boosters: 5 things to know

    The Food and Drug Administration earlier this month greenlighted updated Covid boosters from Pfizer...

    New Covid vaccine rollout hampered by canceled appointments, insurance issues

    Some people seeking the newest Covid vaccines are running into high demand, insurance headaches...

    As Covid cases rise, what to know about Paxlovid

    Covid cases and hospitalizations have risen again. Some Americans are anxious about possibly getting...

    Long Covid blood test shows differences in the immune system, research finds

    More than three years into the pandemic, the millions of people who have suffered...